<DOC>
	<DOCNO>NCT01292837</DOCNO>
	<brief_summary>To evaluate efficacy safety Levetiracetam dry syrup dose 60 mg/kg/day 3000 mg/day use adjunctive therapy Japanese pediatric patient age â‰¥4 &lt; 16 year uncontrolled Generalized Tonic-Clonic ( GTC ) seizures despite treatment 1 2 Anti-Epileptic Drugs ( AEDs ) .</brief_summary>
	<brief_title>A Study Levetiracetam Japanese Pediatric Patients With Generalized Tonic-clonic Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>An epileptic patient generalize tonicclonic seizure classifiable accord International League Against Epilepsy classification epileptic seizure ( Epilepsia , 1981 ) A patient stable dose 1 2 antiepileptic drug last 4 week ( potassium bromide sodium bromide last 12 week ) prior Combined Baseline Period Combined Baseline Period Presence sign ( clinical imaging procedure ) suggest progressive brain lesion/disease , particular , progressive disorder epileptic seizure Diagnosis LennoxGastaut Syndrome Confirmed focal epilepsy base clinical sign ( seizure type ) , consistent electroencephalogram magnetic resonance imaging feature A history convulsive nonconvulsive status epilepticus take concomitant antiepileptic drug last 3 month prior Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Generalized tonic-clonic seizure</keyword>
</DOC>